Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeGEV for Relapsed/Refractory Hodgkin's Lymphoma
NCT01884441Phase 2Unknown
- Sponsor
- Armando Santoro
- Start
- Jul 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in Hodgkin lymphoma (HL), sponsored by Armando Santoro. Status: unknown.
02
Drugs
bendamustine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01884441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01884441.